This presentation examines the evolving regulatory landscape of clinical research compliance, emphasizing how multiple federal and state agencies—beyond the FDA—are shaping enforcement priorities in the clinical trial space.
This program will help attorneys representing clients who suffer from a substance abuse disorder understand the issues and causes of action arising from their poor and inadequate treatment.
This course will explore product liability lawsuits filed against cosmetic companies for failure to warn consumers about a link to reproductive health problems.